Cargando…

Fatigue in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapy: predictors and the relationship with physical activity

Fatigue is a common side effect of tyrosine kinase inhibitor (TKI) therapy in patients with chronic myeloid leukemia (CML). However, the prevalence of TKI-induced fatigue remains uncertain and little is known about predictors of fatigue and its relationship with physical activity. In this study, 220...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janssen, Lando, Blijlevens, Nicole M.A., Drissen, Meggie M.C.M., Bakker, Esmée A., Nuijten, Malou A.H., Janssen, Jeroen J.W.M., Timmers, Silvie, Hopman, Maria T.E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252933/ https://www.ncbi.nlm.nih.gov/pubmed/32616528 http://dx.doi.org/10.3324/haematol.2020.247767

Ejemplares similares

Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy
por: Janssen, Lando, et al.
Publicado: (2023)

Skeletal muscle toxicity associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
por: Janssen, L., et al.
Publicado: (2019)

The magnitude and progress of lean body mass, fat‐free mass, and skeletal muscle mass loss following bariatric surgery: A systematic review and meta‐analysis
por: Nuijten, Malou A.H., et al.
Publicado: (2021)

Changes in Physical Activity in Relation to Body Composition, Fitness and Quality of Life after Primary Bariatric Surgery: a Two-Year Follow-Up Study
por: Nuijten, Malou A. H., et al.
Publicado: (2020)

Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia
por: Verhagen, Noor E., et al.
Publicado: (2023)

Association Between Statin Use and Prevalence of Exercise-Related Injuries: A Cross-Sectional Survey of Amateur Runners in the Netherlands
por: Bakker, Esmée A., et al.
Publicado: (2017)

The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome
por: Hoxhaj, Alma, et al.
Publicado: (2022)

The use of hydroxyurea pretreatment in chronic myeloid leukemia in the current tyrosine kinase inhibitor era
por: Kockerols, Camille C.B., et al.
Publicado: (2022)

Increase in Physical Activity After Bariatric Surgery Demonstrates Improvement in Weight Loss and Cardiorespiratory Fitness
por: Tettero, Onno M., et al.
Publicado: (2018)

Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia
por: Boons, Christel CLM, et al.
Publicado: (2014)

Autologous Stem Cell Transplantation in elderly Acute Myeloid Leukemia
por: Ossenkoppele, Gert J, et al.
Publicado: (2013)

Rate and Determinants of Excessive Fat-Free Mass Loss After Bariatric Surgery
por: Nuijten, Malou A. H., et al.
Publicado: (2020)

Cognitive Behavioral Therapy for Treatment-Related Fatigue in Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitors: A Mixed-Method Study
por: Poort, Hanneke, et al.
Publicado: (2019)

Changes in Fat-Free Mass, Protein Intake and Habitual Physical Activity Following Roux-en-Y Gastric Bypass Surgery: A Prospective Study
por: Nuijten, Malou A. H., et al.
Publicado: (2023)

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach
por: Ector, Geneviève ICG, et al.
Publicado: (2020)

Letter to the Editor: “Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment”
por: Allard, Neeltje A E, et al.
Publicado: (2020)

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
por: Boons, Christel C. L. M., et al.
Publicado: (2020)

Mitochondrial complex III activity: from invasive muscle biopsies to patient-friendly buccal swab analysis
por: Somers, Tim, et al.
Publicado: (2023)

Expert opinion—management of chronic myeloid leukemia after resistance to second-generation tyrosine kinase inhibitors
por: Hochhaus, Andreas, et al.
Publicado: (2020)

Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population
por: Kockerols, Camille C.B., et al.
Publicado: (2022)

Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia
por: Geelen, Inge G.P., et al.
Publicado: (2017)

Association of FLT3-internal tandem duplication length with overall survival in acute myeloid leukemia: a systematic review and meta-analysis
por: Polak, Tobias B., et al.
Publicado: (2022)

Effect of a personalised mHealth home-based training application on physical activity levels during and after centre-based cardiac rehabilitation: rationale and design of the Cardiac RehApp randomised control trial
por: Vonk, Thijs, et al.
Publicado: (2021)

The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018
por: Maas, Carolien C. H. M., et al.
Publicado: (2021)

High-risk additional cytogenetic aberrations in a Dutch chronic phase chronic myeloid leukemia patient population
por: Kockerols, Camille C.B., et al.
Publicado: (2023)

Protein Intake and Distribution in Relation to Physical Functioning and Quality of Life in Community-Dwelling Elderly People: Acknowledging the Role of Physical Activity
por: ten Haaf, Dominique S. M., et al.
Publicado: (2018)

A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands
por: Claudiani, Simone, et al.
Publicado: (2022)

Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment
por: de Leeuw, David C., et al.
Publicado: (2022)

PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
por: Djodikromo, Melissa, et al.
Publicado: (2023)

Identifying Reasons for Nonattendance and Noncompletion of Cardiac Rehabilitation: INSIGHTS FROM GERMANY AND THE NETHERLANDS
por: Vonk, Thijs, et al.
Publicado: (2021)

Protein supplementation improves lean body mass in physically active older adults: a randomized placebo‐controlled trial
por: ten Haaf, Dominique S.M., et al.
Publicado: (2019)

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters
por: van Gils, Noortje, et al.
Publicado: (2022)

Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial
por: Djodikromo, Melissa F, et al.
Publicado: (2023)

Clinical Utility of the Cardiorespiratory Optimal Point in Patients with Heart Failure
por: KROESEN, SOPHIE H., et al.
Publicado: (2023)

The Effect of a Single Bout of Exercise on Vitamin B2 Status Is Not Different between High- and Low-Fit Females
por: Janssen, Joëlle J. E., et al.
Publicado: (2021)

Correlates of Total and domain-specific Sedentary behavior: a cross-sectional study in Dutch adults
por: Bakker, Esmée A., et al.
Publicado: (2020)

Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
por: Griffioen, Mila S., et al.
Publicado: (2022)

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
por: Cloos, Jacqueline, et al.
Publicado: (2018)

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
por: Tettero, Jesse M., et al.
Publicado: (2023)

Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome
por: Drissen, Meggie M. C. M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7uuc75c0oq5dksa3ehp1pmtrfk